0000890821
EX-FILING FEES
Common Stock, par value $0.01 per share ("Common Stock")
0000890821
2025-12-19
2025-12-19
0000890821
1
2025-12-19
2025-12-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit
107
Calculation
of Filing Fee Tables
Form
S-8
(Form
Type)
Enveric
Biosciences, Inc.
(Exact
Name of Each Registrant as Specified in its Charter)
Table
1: Newly Registered and Carry Forward Securities
Security Type | |
Security Class Title | |
Fee Calculation or Carry Forward Rule | |
Amount Registered (1) | | |
Proposed Maximum Offering Price Per Unit | | |
Maximum Aggregate Offering Price | | |
Fee Rate | | |
Amount of Registration Fee | |
| Equity | |
Common Stock, par value $0.01 per share (“Common Stock”) | |
Rule 457(c) and Rule 457(h) | |
| 131,110 | | |
$ | 5.33 | (2) | |
$ | 698,816.30 | | |
| 0.00013810 | | |
$ | 96.50 | |
| Total Offering Amounts | |
| | | |
$ | 698,816.30 | | |
| 0.00015310 | | |
$ | 96.50 | |
| Total Fees Previously Paid | |
| | | |
| | | |
| | | |
| - | |
| Total Fee Offsets | |
| | | |
| | | |
| | | |
| - | |
| Net Fee Due | |
| | | |
| | | |
| | | |
$ | 96.50 | |
| (1) |
Pursuant
to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the number of shares registered hereunder
includes such additional number of shares of common stock, par value $0.01 per share (the “Common Stock”) of Enveric
Biosciences, Inc. (the “Company”), as are required to prevent dilution resulting from a stock split, stock dividend or
similar transaction. |
| |
|
| (2) |
The
offering price has been estimated solely for the purposes of the calculation of the registration fee. The offering price has been
calculated in accordance with the manner described in paragraphs (c) and (h) of Rule 457 under the Securities Act and is based upon
the average of high and low prices reported by the Nasdaq Capital Market on December 18, 2025, a date within five (5) business days
prior to the date of the filing of this Registration Statement. |
N/A